Abiopharma

🔍 Holland Noel R. (Director)

Company: Columbia Financial, Inc. (CLBK)

Report Date: 2026-06-26

Detailed Transactions and Holdings:

• Acquired 14 shares of Common Stock at $20.86 per share (Direct)
  Date: 2026-06-26 | Code: A | equity_swap_involved: 0 | shares_owned_after: 10,071.30 | transaction_form_type: 4 | Footnotes: F1
• Holds 0 shares of Common Stock (Direct)
  Date: 2026-06-26 | Code: H | shares_owned_after: 36,726.00
• Holds 0 shares of Common Stock (Direct)
  Date: 2026-06-26 | Code: H | nature_of_ownership: By SEP-IRA | shares_owned_after: 46,280.00
• Holds 0 shares of Common Stock (Direct)
  Date: 2026-06-26 | Code: H | nature_of_ownership: Stock Award V | shares_owned_after: 2,952.00 | Footnotes: F2
• Holds 83,294 shares of Stock Options (right to buy) at $15.6 per share (Derivative)
  Date: 2026-06-26 | Code: H | Expires: 2029-07-23 | Exercise: 2020-07-23 | shares_owned_after: 83,294.00 | Footnotes: F3

Footnotes:

• F1: Represents phantom stock purchased, on a non-discretionary basis, by the trustee of the Bank's rabbi trust maintained in connection with the Columbia Bank Stock Based Deferral Plan, a non-qualified stock-based deferral plan. Stock unit interests under the Columbia Bank Stock Based Deferral Plan will be settled in shares of stock upon distribution to the reporting person.
• F2: Stock Awards granted pursuant to the Columbia Financial, Inc. 2019 Equity Incentive Plan which vest in one year on March 12, 2027.
• F3: Stock Options granted pursuant to the Columbia Financial, Inc. 2019 Equity Incentive Plan are fully vested and exercisable.